Group sequential crossover trial designs with strong control of the familywise error rate (Q4689943): Difference between revisions
From MaRDI portal
Changed an Item |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Q3067798 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A group sequential approach to crossover trials for average bioequivalence / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: On Deriving the Inverse of a Sum of Matrices / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Q4264744 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Ethical considerations concerning treatment allocation in drug development trials / rank | |||
Normal rank | |||
Latest revision as of 00:59, 17 July 2024
scientific article; zbMATH DE number 6959436
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Group sequential crossover trial designs with strong control of the familywise error rate |
scientific article; zbMATH DE number 6959436 |
Statements
Group sequential crossover trial designs with strong control of the familywise error rate (English)
0 references
22 October 2018
0 references
clinical trial
0 references
crossover
0 references
familywise error rate
0 references
group sequential
0 references
linear mixed model
0 references
0 references
